Bhaskar Sambasivan joins CitiusTech as CEO

Sambasivan will build on the success of CitiusTech as a leader in healthcare digital transformation, and drive scalability and innovation to power the next phase of growth

CitiusTech has appointed Bhaskar Sambasivan as Chief Executive Officer effective November 1, 2021. Sambasivan joined CitiusTech as President in May 2021 and has been working closely with Rizwan Koita, CEO, as part of a structured leadership transition process.


Before joining CitiusTech, Sambasivan was President of Patient Services and Chief Strategy Officer of EVERSANA, a leading life sciences platform company. Before this, he spent close to 15 years at Cognizant as the Global Head of Life Sciences. Under his leadership, Cognizant’s Life Sciences business grew over thirty-fold in 15 years. Before Cognizant, he spent many years with Siebel/Oracle and PricewaterhouseCoopers in key leadership roles. Sambasivan was recognised as a PharmaVOICE Top 100 leader in both 2017 and 2018 for his industry contributions.

“Sambasivan is an immensely accomplished healthcare industry leader with a clear vision for digital innovation and a 25-year track record of scaling technology-enabled healthcare businesses,” said William Winkenwerder, MD, Chairman, CitiusTech. “We are excited that his ideas, insights and strategy will further accelerate CitiusTech’s success and growth momentum.”

“As co-founder of CitiusTech, it has been a privilege to lead the organization and see it scale to over 5,400 healthcare technology professionals serving over 120 healthcare organizations,” said Rizwan Koita, co-founder and outgoing CEO.

Sambasivan said. “We have a great leadership team, a highly client-centric culture, deep healthcare and technology expertise and strong presence in a broad range of healthcare market segments. I am excited to lead the organisation and work with our clients and partners to build innovative business and technology solutions that address key challenges and priorities across the healthcare ecosystem.”

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.


Related Articles

Leave a Reply

Back to top button